Cannabis Zynerba Pharmaceuticals Announces Poster Presentation at the Annual Meeting of the American College of Neuropsychopharmacology November 29, 2022
Cannabis KemPharm Announces Appointment of Christopher Posner as New Independent Director November 29, 2022
Cannabis Zynerba Pharmaceuticals Announces Publication of Data from Phase 3 CONNECT-FX Study of Zygel(TM) in the Journal of Neurodevelopmental Disorders November 28, 2022
Cannabis Global Tech Industries Group, Inc. Updates Shareholders on Exercised Warrants Progress November 24, 2022